Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 75,077 | 59,220 | 47,578 | 45,669 | 40,903 |
| Operating Income | -75,077 | -59,220 | -47,578 | -45,669 | -40,903 |
| Interest Expense | 1,233 | 1,245 | 1,268 | 1,274 | 2,338 |
| Other Income | -82,676 | -16,633 | -1,590 | -20,322 | 497 |
| Pre-tax Income | -158,986 | -77,098 | -50,436 | -67,265 | -42,744 |
| Net Income Continuous | -158,986 | -77,098 | -50,436 | -67,265 | -42,744 |
| Net Income | $-158,986 | $-77,098 | $-50,436 | $-67,265 | $-42,744 |
| EPS Basic Total Ops | -1.44 | -0.71 | -0.51 | -0.78 | -0.50 |
| EPS Basic Continuous Ops | -1.44 | -0.71 | -0.50 | -0.78 | -0.50 |
| EPS Diluted Total Ops | -1.44 | -0.71 | -0.43 | -0.78 | -0.50 |
| EPS Diluted Continuous Ops | -1.44 | -0.71 | -0.51 | -0.78 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -1.44 | -0.71 | -0.45 | -0.78 | -0.50 |
| EBITDA(a) | $-76,441 | $-58,629 | $-47,120 | $-45,526 | $-40,903 |